TREATMENT OF SOCIAL PHOBIA--MEDIATORS AND MODERATORS

社交恐惧症的治疗——中介者和调节者

• 批准号: 6165186
• 负责人: Stefan G. Hofmann
• 金额: $ 15.36万
• 依托单位: BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-05-01 至 2003-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6165186
• 关键词: anxiety disorders; behavior test; clinical research; cognitive behavior therapy; emotional adjustment; fear; health care cost /financing; human subject; human therapy evaluation; outcomes research; performance; personality disorders; phobias; psychophysiology; psychosocial rehabilitation; questionnaires; social behavior; speech

DESCRIPTION (Applicant's abstract): Social phobia is a very prevalent and debilitating disorder with public speaking anxiety being the most common tear among socially phobic individuals. Although there are a number of effective psychosocial treatments for social phobia (e.g., cognitive-behavioral treatments and exposure therapy) very little is known about the underlying mechanism of therapeutic change (i.e., the mediators of change), and the variables that are predictive. of treatment outcome (i.e., the moderators of change). Furthermore; it is unclear why treating individuals for their public speaking anxiety can generalize to other untreated social fears. The primary goal of the present study is to identify the mediators and moderators of change in the treatment of social phobia, and, in so doing suggest a common mechanism of action for all brief psychosocial interventions. Perceived self-efficacy of social behavior, negative cognitive appraisal (estimated social costs), and perceived emotional control will be considered as potential mediators; avoidant personality disorder and the generalized subtype of social phobia will be considered as potential predictors for poor treatment outcome. Individuals meetings criteria for social phobia with significant fear of public speaking will be randomly assigned to either a comprehensive cognitive-behavioral treatment for social phobia (n=43), a performance-based exposure treatment for public speaking anxiety without cognitive intervention (n=43), or a waitlist control group (n=43). Clinician ratings, behavioral tests, cognitive assessments, subjective ratings, and physiological measures will be employed to determine the degree of therapeutic gains in various social phobia domains. The main hypothesis is that perceived emotional control will mediate treatment outcome and generality of effectiveness independent of the specific treatment condition.

描述（申请人的摘要）：社交恐惧症是一种非常普遍的， 以公开演讲焦虑为最常见的衰弱性障碍 社交恐惧症患者的眼泪 虽然有一些 对社交恐惧症的有效心理社会治疗（例如， 认知行为治疗和暴露疗法）知之甚少 关于治疗变化的潜在机制（即，调解人 变化），以及预测的变量。 治疗结果（即， 变革的主持人）。 此外，目前还不清楚为什么治疗 个人的公开演讲焦虑可以推广到其他人 未处理的社交恐惧 本研究的主要目标是确定中介体， 社交恐惧症治疗的变化的调节者，并且，在这样做的过程中， 这表明了所有简短社会心理学的共同作用机制 干预措施。 社会行为自我效能感，消极 认知评估（估计的社会成本），以及感知的情感 控制将被视为潜在的中介;回避型人格 障碍和社交恐惧症的广义亚型将被视为 不良治疗结果的潜在预测因素。 个体符合社交恐惧症的标准， 公开演讲将被随机分配到一个全面的 社交恐惧症的认知行为治疗（n=43），一个基于表现的 无认知障碍的公众演讲焦虑症的暴露治疗 干预组（n=43）或候补对照组（n=43）。 临床医生评级， 行为测试、认知评估、主观评级，以及 将采用生理测量来确定 在各个社交恐惧症领域的治疗成果。 主要的假设是 感知情绪控制将介导治疗结果， 独立于具体治疗条件的有效性的一般性。